Entrepreneur and Dallas Mavericks owner Mark Cuban has voiced his strong support for the TrumpRx program and its Cost Plus Drugs model, highlighting it as a major step toward price transparency and affordability in the U.S. pharmaceutical industry. This was reported by The Gateway Hispanic.
Cuban described the initiative as “amazing” and emphasized its potential to deliver meaningful savings for seniors and patients across the nation. As the founder of CostPlusDrugs.com, a platform designed to simplify access to affordable medications, Cuban praised the TrumpRx program for leveraging transparency to rebuild trust between patients and the healthcare system.
The TrumpRx initiative allows consumers to see exactly how drug prices are calculated and how much profit is made on each sale. Through the TrumpRx API and the CostPlusDrugs.com platform, patients receive daily updates on drug prices, featuring full cost breakdowns and a flat 15% profit margin. This model removes layers of middlemen, including Pharmacy Benefit Managers (PBMs), who have long been criticized for inflating prescription costs.
“Trust is what we truly sell in this industry, and that has allowed us to grow so quickly,” Cuban said. He pointed out that by connecting manufacturers directly to patients, the TrumpRx model—alongside the Most Favored Nation (MFN) program—is making brand-name drugs more affordable and accessible.
While acknowledging that the program does not solve every issue in the healthcare system, Cuban believes it represents a significant improvement in price clarity and patient savings. Seniors, who are most affected by rising prescription costs, stand to benefit the most from these changes.
Cuban also noted that the structure of the TrumpRx program reflects the broader goals of President Donald Trump’s administration: providing practical, market-based solutions that prioritize patients and reduce the influence of corporate intermediaries. The program’s emphasis on consumer choice and transparency aligns with conservative efforts to bring more accountability to healthcare spending.
“The combination of transparency, savings, and direct access to medications gives patients more control and confidence,” Cuban explained. He emphasized that rebuilding public trust in healthcare depends on honest pricing and eliminating unnecessary costs.
Support from prominent business leaders like Cuban has brought renewed attention to TrumpRx’s promise of efficiency and cost reduction. Advocates argue that the initiative showcases a model of free-market healthcare reform that delivers real benefits to citizens without expanding government involvement.
As Cuban continues to champion affordable drug pricing, the TrumpRx program remains a focal point in the ongoing debate over how to lower healthcare costs while empowering patients through increased information and competition.
https://www.lifezette.com/2025/10/mark-cuban-endorses-trumprx-program-citing-transparency-savings-for-patients/